首页> 外文OA文献 >The comparison of lopinavir/ritonavir combination and favipiravir in COVID-19 treatment

【2h】

The comparison of lopinavir/ritonavir combination and favipiravir in COVID-19 treatment

机译：Lopinavir / Ritonavir组合和FaviPiravir在Covid-19治疗中的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling [J] . Sora Yasri, Viroj Wiwanitkit 亚太热带医药杂志（英文版） . 2020,第003期
2. Comparison of non-severe COVID-19 pneumonia patients treated with lopinavir/ritonavir and favipiravir [J] . Omer AYTEN, Bengü ?AYLAN Journal of surgery and medicine. . 2020,第11期

机译：非严重Covid-19肺炎治疗Lopinavir / Ritonavir和FaviPiravir的肺炎患者的比较
3. A 96-Week Comparison of Lopinavir-Ritonavir Combination Therapy Followed by Lopinavir-Ritonavir Monotherapy versus Efavirenz Combination Therapy. [J] . Hanna GJ The Journal of Infectious Diseases . 2008,第2期

机译：洛吡那韦-利托那韦单药疗法与依法韦仑联合治疗后洛美那韦-利托那韦单药治疗96周比较。
4. A 96-Week Comparison of Lopinavir-Ritonavir Combination Therapy Followed by Lopinavir-Ritonavir Monotherapy versus Efavirenz Combination Therapy [J] . D. William Cameron1 Barbara A. da Silva3 Jose R. Arribas6 Robert A. Myers4 Nicholaos C. Bellos5 Norbert Gilmore2 Martin S. King3 Barry M. Bernstein3 Scott C. Brun3 and George J. Hanna3 Journal of Infectious Diseases . 2008,第2期

机译：洛吡那韦-利托那韦单药治疗与依法韦仑联合治疗后洛美那韦-利托那韦单药治疗96周比较
5. A pharmacokinetic model of lopinavir in combination with ritonavir in human [C] . Duangchaemkarn Khanita, Reisfeld Brad, Lohitnavy Manupat Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2014

机译：洛匹那韦联合利托那韦在人体内的药代动力学模型
6. Cost-Effectiveness Analysis of Nevirapine vs. Ritonavir-Boosted Lopinavir in HIV-infected Children With Peripartum Nevirapine Exposure In Resource-Constrained Areas From Payer's Perspective. [D] . Godwin, Onyeka Peter. 2014

机译：从付款人的角度来看，在资源受限地区感染了围产期尼维拉平的HIV感染儿童中，奈韦拉平vs.利托那韦促进洛匹那韦的成本-效果分析。
7. No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison [O] . Roberta Gagliardini, Alessandro Cozzi-Lepri, Andrea Mariano, 2021

机译：没有Covid-19住院的洛诺维尔/ Ritonavir Plus羟氯喹对羟基氯喹与护理标准的疗效无关：非随机比较
8. Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19 [O] . B. K. Romanov 2020

机译：羟基氯喹，FaviPiravir以及Lopinavir和Ritonavir的组合治疗新冠状病毒感染Covid-19的“第一波”

The comparison of lopinavir/ritonavir combination and favipiravir in COVID-19 treatment

著录项

引文网络

相似文献

相关主题

期刊订阅